Concepedia

Dorothée Bleckmann

DB

8

Publications

424

Citations

8

H-Index

2003

Active since

Affiliations

Novartis (Switzerland)(Current)

University of Basel

Novartis Institutes for BioMedical Research

Massachusetts General Hospital

Dorothée Bleckmann is an author at Novartis (Switzerland) specializing in medicine, cell biology, and high-throughput screening.

Top concepts

Publications per year

2003–2017

8

Publications

8

Transneuronal propagation of mutant huntingtin contributes to non–cell autonomous pathology in neurons

Eline Pecho‐Vrieseling, Claus Rieker, Sascha Fuchs et al. · Nature Neuroscience · 2014 · 176 citations

, , +13

The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease

Jonathan H. Fox, Teal Connor, Vanita Chopra et al. · Molecular Neurodegeneration · 2010 · 95 citations · Full text

Activation of Muscle-specific Receptor Tyrosine Kinase and Binding to Dystroglycan Are Regulated by Alternative mRNA Splicing of Agrin

Patrick Scotton, Dorothée Bleckmann, Michael Stebler et al. · Journal of Biological Chemistry · 2006 · 47 citations · Full text

A quantitative homogeneous assay for fragile X mental retardation 1 protein

Gabi Schutzius, Dorothée Bleckmann, Sandra Kapps-Fouthier et al. · Journal of Neurodevelopmental Disorders · 2013 · 26 citations · Full text

Huntingtin cleavage product A forms in neurons and is reduced by gamma-secretase inhibitors

Kimberly B. Kegel, Ellen Sapp, J. Steven Alexander et al. · Molecular Neurodegeneration · 2010 · 24 citations · Full text

Rows per page

1–5 of 8